Loading...
The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?
For over one decade Glycoproteins IIb/IIIa inhibitors (GPI) have been administered to prevent coronary artery thrombosis. Initially these agents were used for acute coronary syndromes and subsequently as adjunctive pharmacotherapy for percutaneous coronary interventions (PCIs). Most benefit of GPI e...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bentham Science Publishers Ltd.
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2779356/ https://ncbi.nlm.nih.gov/pubmed/19936282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/157340308784245793 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|